cp wire

CP Wire Articles

Myriad and Pfizer Sign Deal to Commercialize Companion Diagnostic

Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced that it has signed a commercialization plan with Pfizer Inc.  The plan is under an existing... read more

Tue, 10/9/18 - 09:44 am
Rgenix Banks $40 Million in Series C Round

Rgenix, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer therapeutics, announced that it has raised $40 million in a Series C financing... read more

Tue, 10/9/18 - 09:23 am
Altimmune Raises $25 million With Direct Offering
  • So far in September and October of 2018 Altimmune has raised over $60 million
  • On 10/6/18 the company presented data that showed that the company's NasoVAX was well-tolerated and... read more
Mon, 10/8/18 - 10:46 am
Veracyte Presents Data Demonstrating Afirma's Success in Reducing Unnecessary Surgery
  • At one site, the surgery rate was reduced by more than 50%
  • Veracyte claims to have removed an estimated $800 million in surgery costs from the healthcare system


... read more

Mon, 10/8/18 - 10:08 am
[release] Following approval in Sweden, Lobsor eyes US entry for new Lecigon treatment for Parkinson’s Disease
Uppsala, October 8, 2018. Lobsor Pharmaceuticals AB, a privately held Swedish company based in Uppsala today announced that Lecigon®, a new therapeutic system for symptomatic treatment... read more
Mon, 10/8/18 - 10:08 am

Pages